핵의학

본문글자크기
  • [Sci Rep.] Surgical outcomes of localization using indocyanine green fluorescence in breast conserving surgery: a prospective study

    [Sci Rep.] Surgical outcomes of localization using indocyanine green fluorescence in breast conserving surgery: a prospective study

    국립암센터 / 이은경, 김석기, 정소연*, 이시연*

  • 출처
    Sci Rep.
  • 등재일
    2021 May 11
  • 저널이슈번호
    11(1):9997. doi: 10.1038/s41598-021-89423-w.
  • 내용

    바로가기  >

    Abstract
    We investigated localization and safe resection margins for breast cancer patients undergoing breast conserving surgery (BCS) using ultrasound-guided indocyanine green fluorescence (ICG-F) marking. From April 2016 to March 2019, we prospectively enrolled 114 patients who underwent BCS using US-guided ICG-F marking and we compared these results with 300 patients who underwent BCS using US-guided skin marking from January 2012 to December 2016. Clinical features, identification rates, status of resection margins, and re-operation rates were analyzed. The ICG-F identification rate was 100% (114/114). The mean approach time for resection of the lesion ICG-F using group was about 13 min. The positive rate of frozen resection margins was 10.5% using ICG-F and 25.0% using sono-guided skin marking (p < 0.01). The rate of additional intraoperative resection was significantly lower in the ICG-F marking group compared to that in the sono-guided skin marking group (8.8% vs. 23.3%, p < 0.01). The rate of final positive resection margins was 3.5% in the ICG-F using group and 14.7% in the sono-guided skin marking group (p < 0.01). The rate of re-operation was 4.4% in the ICG-F using group and 4% in the sono-guided group (p = 0.79). At follow-up after the operation using ICG-F, no complications occurred. Using ICG-F during BCS could be a safe, sophisticated method for localization.

     

     

    Affiliations

    Eun-Gyeong Lee #  1 , Seok-Ki Kim #  2 , Jai Hong Han  1 , Dong-Eun Lee  3 , So-Youn Jung  4 , Seeyoun Lee  5
    1 Department of Surgery, Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, 323 Ilsan ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10408, South Korea.
    2 Department of Nuclear Medicine, National Cancer Center, Goyang, South Korea.
    3 Biostatistics Collaboration Team, Research Core Center, Research Institute of National Cancer Center, Goyang, South Korea.
    4 Department of Surgery, Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, 323 Ilsan ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10408, South Korea. goje1@ncc.re.kr.
    5 Department of Surgery, Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, 323 Ilsan ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10408, South Korea. seeyoun@ncc.re.kr.
    #

  • 연구소개
    유방암에서 유방보존술을 시행할 때 다양한 방법으로 병변 국소화를 시행하고 있습니다. 그중 근적외선 형광유도 병변 국소화 기술을 조기 유방암에 적용한 전향적 임상시험 논문입니다. 인도시아닌그린(ICG)는 초록색을 띄는 염료로 근적외선 카메라를 통해 확인 가능한 형광 염료로, 여러 암에서 다양한 국소화 방법으로 사용이 점차 증가 하고 있습니다. 최근에는 유방암이나 악성 흑색종에서 감시림프절 생검을 위해 사용되고 있습니다. 따라서, 잘 촉지되지 않는 조기 유방암 병변에 적용하게 되면 좀 더 용이하고 정확한 유방 종양 절제가 가능하게 되며 이는 연구자들과 임상의에게 도움이 될 만한 좋은 정보라 생각합니다.
  • 덧글달기
    덧글달기
       IP : 3.140.198.43

    등록